Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
Sylvie Job(La Ligue Contre le Cancer), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Irena Drašković(Centre National de la Recherche Scientifique), Luis Jaime Castro‐Vega(Centre National de la Recherche Scientifique), Arturo Londoño‐Vallejo(Centre National de la Recherche Scientifique), Judith Favier(Inserm), Estelle Robidel(Délégation Paris 5), Aurélien de Reyniès(La Ligue Contre le Cancer), Mathilde Sibony(Environmental Protection Agency), Charles Lépine(Nantes Université), Tchao Méatchi(Assistance Publique – Hôpitaux de Paris), Jérôme Cros(Université Paris Cité), Nelly Burnichon(Inserm), Laurence Amar(Unit of Functional and Adaptive Biology), Alexandre Buffet(Inserm), Virginie Verkarre(Université Paris Cité), Annabelle Vénisse(Assistance Publique – Hôpitaux de Paris), Jérôme Bertherat(Centre National de la Recherche Scientifique)
Cited by 129
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
The ratio of the nucleon structure functions F2N for iron and deuterium
|Physics Letters B|1983|1.1k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772